Research Article

You have full text access to this OnlineOpen article

Erk1/2 signaling is required for Tgf-β2–induced suture closure

  1. Lynne A. Opperman*,
  2. Claudia R. Fernandez,
  3. Sarah So,
  4. Joseph T. Rawlins

Article first published online: 7 DEC 2005

DOI: 10.1002/dvdy.20656

Issue

Developmental Dynamics

Developmental Dynamics

Special Issue: Craniofacial Development Special Issue

Volume 235, Issue 5, pages 1292–1299, May 2006

Additional Information

How to Cite

Opperman, L. A., Fernandez, C. R., So, S. and Rawlins, J. T. (2006), Erk1/2 signaling is required for Tgf-β2–induced suture closure. Dev. Dyn., 235: 1292–1299. doi: 10.1002/dvdy.20656

Author Information

  1. Department of Biomedical Sciences, Baylor College of Dentistry, Texas A&M University System Health Science Center, Dallas, Texas

*Department of Biomedical Sciences, Baylor College of Dentistry, Texas A&M University System Health Science Center, PO Box 660677, Dallas, TX 75266-0677

Publication History

  1. Issue published online: 19 APR 2006
  2. Article first published online: 7 DEC 2005
  3. Manuscript Accepted: 2 NOV 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (360K)

REFERENCES

  • Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M. 1996. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet 14: 174–176.
  • Centrella M, Ji C, Casinghino S, McCarthy TL. 1996. Rapid flux in transforming growth factor-beta receptors on bone cells. J Biol Chem 271: 18616–18622.
  • Chong S, Mitchell R, Moursi AM, Winnard P, Wolfgang Losken H, Bradley J, Ozerdem OR, Azari K, Acarturk O, Opperman LA, Siegel MI, Mooney MP. 2003. Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgf-beta3) in rabbits with delayed-onset craniosynostosis. Anat Rec 274: 962–971.
    Direct Link:
  • Chu CL, Reenstra WR, Orlow DL, Svoboda KK. 2000. Erk and PI-3 kinase are necessary for collagen binding and actin reorganization in corneal epithelia. Invest Ophthalmol Vis Sci 41: 3374–3382.
  • Edlund S, Landstrom M, Heldin CH, Aspenstrom P. 2002. TGF-beta-induced mobilisation of the actin cytoskeleton requires signalling by the small GTPases Cdc42 and RhoA. Mol Biol Cell 13: 902–914.
  • El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A, Bonaventure J. 1997. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15: 42–46.
  • Engel ME, McDonnell MA, Law BK, Moses HL. 1999. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274: 37413–37420.
  • Hay E, Lemonnier J, Fromigue O, Marie PJ. 2001. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276: 29028–29036.
  • Hirano S, Rees RS, Gilmont RR. 2002. MAP kinase pathways involving hsp27 regulate fibroblast-mediated wound contraction. J Surg Res 102: 77–84.
  • Hocevar BA, Brown TL, Howe PH. 1999. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18: 1345–1356.
  • Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD, Jabs EW. 1997. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 15: 36–41.
  • Ignelzi MA Jr, Wang W, Young AT, Carinci F, Bodo M, Tosi L, Francioso F, Evangelisti R, Pezzetti F, Scapoli L, Martinelli M, Baroni T, Stabellini G, Carinci P, Bellucci C, Lilli C, Volinia S. 2003. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures: expression profiles of craniosynostosis-derived fibroblasts. J Bone Miner Res 18: 751–759.
    Direct Link:
  • Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB, et al. 1993. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75: 443–450.
  • Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao JI, Charnas LR, Jackson CE, Jaye M. 1994. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2 [published erratum appears in Nat Genet 1995;9:451]. Nat Genet 8: 275–279.
  • Kim HJ, Rice DP, Kettunen PJ, Thesleff I. 1998. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125: 1241–1251.
  • Kim HJ, Lee MH, Park HS, Park MH, Lee SW, Kim SY, Choi JY, Shin HI, Ryoo HM. 2003. Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev Dyn 227: 335–346.
    Direct Link:
  • Kretzschmar M, Doody J, Massague J. 1997. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389: 618–622.
  • Lai CF, Cheng SL. 2002. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem 277: 15514–15522.
  • Langholz O, Roeckel D, Petersohn D, Broermann E, Eckes B, Krieg T. 1997. Cell–matrix interactions induce tyrosine phosphorylation of MAP kinases ERK1 and ERK2 and PLCgamma-1 in two-dimensional and three-dimensional cultures of human fibroblasts. Exp Cell Res 235: 22–27.
  • Liu YH, Ma L, Wu LY, Luo W, Kundu R, Sangiorgi F, Snead ML, Maxson R. 1994. Regulation of the Msx2 homeobox gene during mouse embryogenesis: a transgene with 439 bp of 5′ flanking sequence is expressed exclusively in the apical ectodermal ridge of the developing limb. Mech Dev 48: 187–197.
  • Liu YH, Kundu R, Wu L, Luo W, Ignelzi MA Jr, Snead ML, Maxson RE Jr. 1995. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci U S A 92: 6137–6141.
  • Lo RS, Wotton D, Massague J. 2001. Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J 20: 128–136.
  • Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37: 275–281.
  • Massague J, Wotton D. 2000. Transcriptional control by the Tgf-B/Smad signaling system. EMBO J 19: 1745–1754.
  • Moursi AM, Winnard PL, Fryer D, Mooney MP. 2003. Delivery of transforming growth factor-beta2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture. Cleft Palate Craniofac J 40: 225–232.
  • Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, et al. 1994. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 8: 269–274.
  • Nakayama K, Tamura Y, Suzawa M, Harada S, Fukumoto S, Kato M, Miyazono K, Rodan GA, Takeuchi Y, Fujita T. 2003. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3–E1 osteoblast-like cells. J Bone Miner Res 18: 827–835.
    Direct Link:
  • Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC. 1995. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10: 1978–1987.
    Direct Link:
  • Opperman LA, Chhabra A, Cho RW, Ogle RC. 1999. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J Craniofac Genet Dev Biol 19: 164–173.
  • Opperman LA, Adab K, Gakunga PT. 2000. TGF-B2 and TGF-B3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 219: 237–247.
    Direct Link:
  • Opperman LA, Moursi A, Sayne JR, Wintergerst AM. 2002. Transforming growth factor-beta 3 (Tgf-β3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. Anat Rec 267: 120–130.
    Direct Link:
  • Potchinsky MB, Weston WM, Lloyd MR, Greene RM. 1997. TGF-beta signaling in murine embryonic palate cells involves phosphorylation of the CREB transcription factor. Exp Cell Res 231: 96–103.
  • Rousse S, Lallemand F, Montarras D, Pincet C, Mazars A, Prunier C, Atfi A, Dubois C. 2001. Transforming growth factor-beta inhibition of insulin-like growth factor binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway. J Biol Chem 276: 46961–46967.
  • Simeone DM, Zhang L, Graziano K, Nicke B, Pham T, Schaefer C, Logsdon CD. 2001. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. Am J Physiol Cell Physiol 281: C311–C319.
  • Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K. 2002. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J Biol Chem 277: 36024–36031.
  • Weinstein M, Yang X, Deng C. 2000. Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev 11: 49–58.
  • Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, et al. 1995. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9: 165–172.
  • Yue J, Frey RS, Mulder KM. 1999. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene 18: 2033–2037.
View Full Article (HTML) Get PDF (360K)